Judge Keenan Rules Against Merck’s Expansion Of Lone Pine Process

On August 12, 2013, we reported on the oral arguments, here.

Last Thursday — while I was busy with other affairs — Judge Keenan declined to follow Merck’s suggestion. He won’t get involved in mini-trials, at the fact discovery stage — for a wider class of Fosamax claims.

And that all makes good sense — in streamlining, rather than compounding — the litigation proceedings. Here is his opinion (in the form of a five page low res PDF).


Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s